Point of Care Coagulation Testing Products Market, By Test Type (Prothrombin time testing products, Activated clotting time (ACT/APTT) testing products, Platelet count, and D-dimer test), By Product Type, By End Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Point of Care Coagulation Testing Products Market size was valued at USD 2,987 Million in 2024, expanding at a CAGR of 6.6% from 2024 to 2032.
The Point of Care (POC) Coagulation Testing Products Market encompasses diagnostic tools and devices used to assess blood clotting parameters directly at or near the site of patient care. These products enable rapid and convenient monitoring of coagulation status, which is critical in emergency settings, surgeries, and for patients undergoing anticoagulant therapy. Key tests include prothrombin time (PT), activated partial thromboplastin time (aPTT), and international normalized ratio (INR). The market includes portable analyzers, test strips, and cartridges used across hospitals, clinics, and home care settings, driven by the need for real-time results, improved patient outcomes, and reduced hospital stays.
Governments worldwide are increasingly prioritizing early detection and management of blood-related disorders, leading to a surge in initiatives such as research funding, awareness campaigns, and subsidies for vital medical devices like POC coagulation testing products. For instance, in March 2022, the National Hemophilia Foundation launched the \"Starts the Conversation\" initiative during Bleeding Disorders Awareness Month to spotlight experiences, research, education, and advocacy efforts related to bleeding disorders. Additionally, in October 2023, the World Federation of Hemophilia introduced the Path to Access Care and Treatment (PACT) program in Mexico, a five-year outreach and diagnosis initiative aimed at improving access to sustainable care for individuals with bleeding disorders. These governmental and organizational efforts are driving the adoption of POC coagulation testing devices, contributing to market growth.
Point of Care Coagulation Testing Products Market- Market Dynamics
Growing Demand for Fast and Accurate Diagnostics in Critical Care Settings
The increasing demand for rapid and accurate diagnostic results in emergency and critical care settings is a major driver of the Point of Care (POC) Coagulation Testing Products Market. In urgent situations such as trauma, stroke, or cardiac surgery, timely assessment of a patient’s coagulation status is essential to guide clinical decisions and prevent life-threatening complications like excessive bleeding or thrombosis. POC coagulation devices deliver immediate results, offering a significant advantage over traditional laboratory tests by enabling faster and more effective interventions. This need for efficiency, combined with rising adoption in operating rooms, intensive care units, and ambulatory care settings, continues to propel market growth on a global scale.
Governments worldwide are increasingly prioritizing early detection and management of blood-related disorders, leading to a surge in initiatives such as research funding, awareness campaigns, and subsidies for vital medical devices like POC coagulation testing products. For instance, in March 2022, the National Hemophilia Foundation in the United States launched the \"Starts the Conversation\" initiative during Bleeding Disorders Awareness Month to spotlight experiences, research, education, and advocacy efforts related to bleeding disorders. Additionally, in October 2023, the World Federation of Hemophilia introduced the Path to Access Care and Treatment (PACT) program in Mexico, a five-year outreach and diagnosis initiative aimed at improving access to sustainable care for individuals with bleeding disorders. These governmental and organizational efforts are driving the adoption of POC coagulation testing devices, contributing to market growth.
Point of Care Coagulation Testing Products Market- Segmentation Analysis:
The global Point of Care Coagulation Testing Products Market is divided into six categories: Test Type, Product Type, End Use and Region.
The Point of Care Coagulation Testing Products Market is segmented by test type into Prothrombin Time (PT) Testing Products, Activated Clotting Time (ACT/aPTT) Testing Products, Platelet Count, D-dimer Test, and Other Test Types. Among these, Prothrombin Time (PT) Testing Products hold the dominant market share, largely due to their vital role in monitoring patients undergoing anticoagulant therapy, such as with warfarin. PT/INR tests are crucial for managing bleeding risks and optimizing drug dosages in patients with cardiovascular diseases and thrombotic disorders. Their advantages—such as ease of use, fast turnaround time, and suitability for both clinical and home care settings—have made PT tests the preferred option for coagulation assessment. The push toward decentralized healthcare and point-of-care decision-making has further fueled their adoption. According to data from the Centers for Medicare & Medicaid Services (CMS), reimbursement claims for PT/INR testing in outpatient and home care settings have increased by over 18% in the past three years, underscoring their expanding role in modern care delivery.
By product type, the market is divided into Instruments and Consumables. Consumables, which include test strips, cartridges, and reagents, dominate this segment due to their recurrent necessity in routine diagnostic testing. Unlike instruments, which are a one-time capital investment, consumables are required for each test, driving continuous demand across hospitals, clinics, and home-based settings. This high usage frequency makes consumables the most significant revenue contributor in the point-of-care coagulation testing market. Additionally, as healthcare systems increasingly adopt rapid, bedside diagnostic solutions, the volume of consumables utilized grows proportionally. According to the U.S. Department of Health and Human Services (HHS), point-of-care diagnostics are expected to represent over 60% of total outpatient testing volume by 2026, a trend that directly supports the rising demand for consumables. Ongoing advancements in consumable technology—such as enhanced accuracy, simplified workflows, and improved user safety—further reinforce their leadership in the market.
Point of Care Coagulation Testing Products Market- Geographical Insights
Geographically, the Point of Care (POC) Coagulation Testing Products Market is segmented across North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa, with individual countries within these regions contributing to market growth based on their healthcare infrastructure and demand.
North America holds a leading position in the POC coagulation testing market, driven by its advanced healthcare infrastructure, high healthcare expenditure, and widespread adoption of innovative diagnostic technologies. The United States plays a major role, supported by a rising prevalence of cardiovascular diseases, an aging population, and the increasing use of anticoagulant therapies. Favorable reimbursement policies, along with the strong presence of key industry players, further contribute to regional growth. Additionally, growing demand for rapid and accurate diagnostic tools in emergency care, outpatient clinics, and home healthcare settings continues to support the widespread adoption of POC coagulation testing devices across hospitals and ambulatory care centers in the region. Europe is another significant market, bolstered by strong governmental support, sophisticated healthcare systems, and heightened awareness around early diagnosis and disease prevention. Countries such as Germany, the United Kingdom, and France are at the forefront of market adoption, owing to their advanced diagnostic infrastructure and the high prevalence of chronic conditions that require regular coagulation monitoring. The region’s commitment to personalized medicine and patient-centered care is further driving demand for rapid, point-of-care solutions. Moreover, Europe’s aging population and the expanding use of home healthcare services are fueling the need for portable, user-friendly coagulation testing products.
Asia Pacific is expected to exhibit the highest compound annual growth rate (CAGR) during the forecast period, driven by rising healthcare expenditure, growing awareness about coagulation disorders, and increasing demand for point-of-care diagnostics in emerging economies such as China and India. The rapidly expanding healthcare infrastructure, the presence of a large patient population, and the increasing prevalence of chronic diseases are key factors contributing to market growth in this region. Government initiatives to improve healthcare access and quality, along with the growing trend towards decentralized and home-based healthcare, are further boosting the adoption of POC coagulation testing in Asia Pacific. Globally, governments are increasingly prioritizing early detection and management of blood-related disorders, leading to a surge in initiatives such as research funding, awareness campaigns, and subsidies for vital medical devices like POC coagulation testing products. For instance, in March 2022, the National Hemophilia Foundation in the United States launched the \"Starts the Conversation\" initiative during Bleeding Disorders Awareness Month to spotlight experiences, research, education, and advocacy efforts related to bleeding disorders. Additionally, in October 2023, the World Federation of Hemophilia introduced the Path to Access Care and Treatment (PACT) program in Mexico, a five-year outreach and diagnosis initiative aimed at improving access to sustainable care for individuals with bleeding disorders. These governmental and organizational efforts are driving the adoption of POC coagulation testing devices, contributing to market growth.
Point of Care Coagulation Testing Products Market- Competitive Landscape:
The competitive landscape of the Point of Care (POC) Coagulation Testing Products Market is defined by the presence of both well-established diagnostic leaders and innovative emerging firms. Major players such as Abbott Laboratories, F. Hoffmann-La Roche, Siemens Healthineers, and Sysmex Corporation lead the market by offering high-precision, user-friendly coagulation analyzers. These companies invest heavily in research and development to improve test sensitivity, device portability, and real-time data analysis, ensuring their technologies meet evolving clinical needs. In parallel, emerging firms like Genrui Biotech and Micropoint Biosciences are gaining traction by introducing affordable and innovative solutions, particularly aimed at expanding access in emerging markets. This dynamic and competitive environment encourages continuous technological advancement, strict regulatory compliance, and broader market penetration. Collectively, these developments are enhancing diagnostic accuracy and accessibility across point-of-care settings worldwide.
Recent Developments:
- In February 2024, Roche launched three new coagulation tests in countries that recognize CE markings, aimed at addressing the rising need for effective monitoring of oral anticoagulant therapy. These tests are designed to improve patient care by delivering faster and more reliable results for healthcare professionals.
- In April 2024, Siemens Healthineers and Sysmex Corporation independently began distributing Siemens’ hemostasis testing solutions across laboratories in Europe and the United States. This strategic move aims to strengthen their presence in the advanced coagulation diagnostics segment, improving testing capabilities and supporting better patient outcomes.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL POINT OF CARE COAGULATION TESTING PRODUCTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott Laboratories
- Alere
- A&T Corporation
- Diagnostica Stago Sas
- F. Hoffmann-La Roche
- Genrui Biotech
- Helena Laboratories
- Horiba
- Medtronic
- Nihon Kohden Corporation
- Micropoint Biosciences
- Sysmex Corporation
- Siemens Healthineers
- Thermo Fisher Scientific
- Others
GLOBAL POINT OF CARE COAGULATION TESTING PRODUCTS MARKET, BY TEST TYPE - MARKET ANALYSIS, 2019 - 2032
- Prothrombin time testing products
- Activated clotting time (ACT/APTT) testing products
- Platelet count
- D-dimer test
- Others test types
GLOBAL POINT OF CARE COAGULATION TESTING PRODUCTS MARKET, BY PRODUCT TYPE - MARKET ANALYSIS, 2019 - 2032
- Instruments
- Consumables
GLOBAL Point of Care Coagulation Testing Products MARKET, BY END USE - MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Diagnostic Centers
- Home Care Settings
- Other End Use
GLOBAL Point of Care Coagulation Testing Products MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Point of Care Coagulation Testing Products Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Point of Care Coagulation Testing Products Market Snippet by Test Type
2.1.2. Point of Care Coagulation Testing Products Market Snippet by Product Type
2.1.3. Point of Care Coagulation Testing Products Market Snippet by End Use
2.1.4. Point of Care Coagulation Testing Products Market Snippet by Country
2.1.5. Point of Care Coagulation Testing Products Market Snippet by Region
2.2. Competitive Insights
3. Point of Care Coagulation Testing Products Key Market Trends
3.1. Point of Care Coagulation Testing Products Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Point of Care Coagulation Testing Products Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Point of Care Coagulation Testing Products Market Opportunities
3.4. Point of Care Coagulation Testing Products Market Future Trends
4. Point of Care Coagulation Testing Products Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Point of Care Coagulation Testing Products Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Point of Care Coagulation Testing Products Market Landscape
6.1. Point of Care Coagulation Testing Products Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Point of Care Coagulation Testing Products Market – By Test Type
7.1. Overview
7.1.1. Segment Share Analysis, By Test Type, 2023 & 2032 (%)
7.1.2. Prothrombin time testing products
7.1.3. Activated clotting time (ACT/APTT) testing products
7.1.4. Platelet count
7.1.5. D-dimer test
7.1.6. Others test types
8. Point of Care Coagulation Testing Products Market – By Product Type
8.1. Overview
8.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
8.1.2. Instruments
8.1.3. Consumables
9. Point of Care Coagulation Testing Products Market – By End Use
9.1. Overview
9.1.1. Segment Share Analysis, By End Use, 2023 & 2032 (%)
9.1.2. Hospitals
9.1.3. Diagnostic Centers
9.1.4. Home Care Settings
9.1.5. Other End Use
10. Point of Care Coagulation Testing Products Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Point of Care Coagulation Testing Products Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Point of Care Coagulation Testing Products Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.8. France
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.8.4. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.8.5. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.9. Italy
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.9.4. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.9.5. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.10. Spain
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.10.4. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.10.5. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.11. United Kingdom
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.3. United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.11.4. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.11.5. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.12. Russia
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.2. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.12.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.12.4. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.13. Netherlands
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.2. Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.13.3. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.13.4. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.14. Sweden
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.2. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.14.4. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.15. Poland
10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.2. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.16.5. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Point of Care Coagulation Testing Products Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.7.5. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.8.5. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.9. South Korea
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.9.4. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.9.5. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.10. Japan
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.10.4. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.10.5. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Point of Care Coagulation Testing Products Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Point of Care Coagulation Testing Products Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Point of Care Coagulation Testing Products Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Abbott Laboratories
11.2.2. Alere
11.2.3. A&T Corporation
11.2.4. Diagnostica Stago Sas
11.2.5. F. Hoffmann-La Roche
11.2.6. Genrui Biotech
11.2.7. Helena Laboratories
11.2.8. Horiba
11.2.9. Medtronic
11.2.10. Nihon Kohden Corporation
11.2.11. Micropoint Biosciences
11.2.12. Sysmex Corporation
11.2.13. Siemens Healthineers
11.2.14. Thermo Fisher Scientific
11.2.15. Others
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
